Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated favorable safety and tolerability in a Phase III open-label study - The ...

Spanish dermatology specialist Almirall has announced that China’s National Medical Products Administration (NMPA) has ...

Sagimet Biosciences (SGMT) stock dips as Chinese partner Ascletis (ASCLF) reports Phase 3 trial data for the U.S. firm's acne ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announced positive topline results from the Phase III open-label study (NCT06248008) evaluating denifanstat (ASC40), a first-in-class, once-daily ...

Almirall, S.A. (ALM) a global pharmaceutical company dedicated to medical dermatology announced today that China’s National Medical Products Administration (NMPA) has approved Seysara® (sarecycline ...

Dandruff shampoo has a number of beneficial uses beyond treating a dry, flaky scalp. Here are just a few of the surprising ...

Gene-editing tools like CRISPR have unlocked new treatments for previously uncurable diseases. Now, researchers at the ...

Say goodbye to breakouts! Try these 8 face washes for acne-prone skin to clear pimples and control excess oil.| Lifestyle ...

Acne risk rises sharply in transmasculine individuals starting testosterone and also affects transfeminine patients on ...

Odds are you have folliculitis.

One of the most common skincare mistakes is trying to fix everything at once. Acne, dark spots, uneven tone, and texture treated in a single routine ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.